Navigation Links
H1N1 Flu Vaccine Very Effective: Study
Date:2/3/2011

THURSDAY, Feb. 3 (HealthDay News) -- A single dose of the H1N1 swine flu vaccine was 93 percent effective during the 2009 pandemic, a new study found.

In order to assess the effectiveness of the vaccine -- known as the AS03-adjuvanted pandemic H1N1 vaccine -- Canadian researchers looked at 552 patients with flu-like illness who visited clinics in four provinces between Nov. 8 and Dec. 5, 2009.

Pandemic H1N1 was detected in 209 (38 percent) of the patients. Two (1 percent) of the patients with H1N1 flu had received a single dose of the H1N1 vaccine at least two weeks before they became ill, compared with 58 (17 percent) of patients who didn't have H1N1 infection.

The findings show that the vaccine was 93 percent effective, said the researchers, who were led by Danuta Skowronski at the British Columbia Centre for Disease Control in Vancouver.

The findings apply not only to Canada but other countries where vaccines were used, and may help guide the further development of influenza vaccine options, the researchers said.

More than 80 percent of the people in the study were younger than 50, so evidence of the effectiveness of the vaccine in the elderly is still needed, they noted.

The study appeared in the Feb. 3 online edition of BMJ.

More information

The U.S. Centers for Disease Control and Prevention has more about H1N1 flu.

-- Robert Preidt

SOURCE: BMJ, news release, Feb. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Last Years H1N1 Flu Vaccine Was Safe, Study Finds
2. Gardasil Vaccine Guards Against HPV in Boys
3. New study identifies potential vaccine to prevent gastritis, ulcer disease, gastric cancer
4. Southampton scientists begin patient trials of new leukemia cancer vaccine
5. Fear of Vaccines Has a Long, Persistent History
6. NIH, Gates Foundation and Colorado State team up to find new approach to a TB vaccine
7. New discovery could lead to vaccines for plague and bacterial pneumonias
8. Nearly Half of Americans Still Suspect Vaccine-Autism Link
9. Researchers unzip MRSA and discover route for vaccine
10. Case Western Reserve/University Hospitals join nationwide HIV vaccine clinical trial
11. Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: